Tricitrasol Solution
NDC 23731-6030
View dosage, usage, ingredients, routes, and UNII mappings.
Product Information
Tricitrasol (trisodium citrate dihydrate) is a NDA-approved product labeled by Citra Labs Llc. This medication is typically used as a acidifying activity [moa]. It is supplied as a solution for extracorporeal administration. This product entry covers the primary NDC 23731-6030 and 2 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
NDC Product Code:
23731-6030
Proprietary Name:
Tricitrasol
Non-Proprietary Name: [1]
Trisodium Citrate Dihydrate
Substance Name: [2]
Trisodium Citrate Dihydrate
NDC Directory Status:
Human Prescription Drug
Product Type: [3]
ACTIVE PRODUCT INCLUDED in the NDC Directory
Code Navigator:
Clinical Specifications
Dosage Form:
Solution
- A clear, homogeneous liquid1 dosage form that contains one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents.
Administration Route(s): [4]
Extracorporeal - Administration outside of the body.
Labeler & Regulatory Data
Labeler Name: [5]
Labeler Code:
23731
Product Label ID:
FDA Application Number: [6]
BN010409
Marketing Category: [8]
NDA - A product marketed under an approved New Drug Application.
Marketing Timeline
Start Marketing Date: [9]
07-10-2003
Listing Expiration Date: [11]
12-31-2026
Exclude Flag: [12]
N
Code Structure Chart
Product Details
What is NDC 23731-6030?
The NDC code 23731-6030 is assigned by the FDA to the product Tricitrasol. It is commonly known by its generic name, trisodium citrate dihydrate. This pharmaceutical product is labeled by Citra Labs Llc and is currently categorized as listed product. The medication is a solution administered via extracorporeal route. In terms of distribution, this product is available in 2 different package configurations. The associated package NDC(s) include: 23731-6030-1, 23731-6030-2. Beyond standard identification, this entry provides technical data including pharmacologic classes, UNII ingredient references, and RxNorm cross-referencing for healthcare systems.
What are the uses of this product?
TriCitrasol® Anticoagulant Sodium Citrate Concentrate, 46.7% Trisodium Citrate, is an anticoagulant used in granulocytapheresis procedures (granulocyte collection by apheresis). Just prior to performing granulocytapheresis, aseptically add 30 mL of
triCitrasol® to 500 mL of the 6% solution of Hydroxyethyl Starch (HES), e.g. Hespan
® 2-8. Agitate the resultant solution for 1 minute to assure a uniform concentration of anticoagulant. The resultant solution of
triCitrasol® and 6% solution of HES contains the following concentration depending upon the volume used:
Volume of
triCitrasol®Volume of HESTotal VolumeFinal Concentration of
triCitrasol®30 mL500 mL (measured from HES bag)530 mL2.6%30 mL558 mL (injected directly into HES bag)588 mL2.4%The
triCitrasol®/HES solution is stable for up to 24 hours at room temperature after mixing.
Refer to the manufacturer's Operator's Manual of the apheresis medical device for the directions to perform the granulocytapheresis procedure.
What are Active Ingredients of this product?
An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
- TRISODIUM CITRATE DIHYDRATE 14 g/30mL - Sodium salts of citric acid that are used as buffers and food preservatives. They are used medically as anticoagulants in stored blood, and for urine alkalization in the prevention of KIDNEY STONES.
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- TRISODIUM CITRATE DIHYDRATE (UNII: B22547B95K)
- ANHYDROUS CITRIC ACID (UNII: XF417D3PSL) (Active Moiety)
Which are the Pharmacologic Classes of this product?
A pharmacologic class is a group of drugs that share the same scientifically documented properties. The following is a list of the reported pharmacologic class(es) corresponding to the active ingredients of this product.
* Please review the full disclaimer at the bottom of this page.
Product & Regulatory Definitions
What is the Non-Proprietary Name? The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
What is the Substance Name? An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
What kind of product is this? Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
What are the Administration Routes? The translation of the route code submitted by the firm, indicating route of administration.
What is the Labeler Name? Name of Company corresponding to the labeler code segment of the Product NDC.
What is the FDA Application Number? This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
What is the Marketing Category? Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
What is the Start Marketing Date? This is the date that the labeler indicates was the start of its marketing of the drug product.
What is the Listing Expiration Date? This is the date when the listing record will expire if not updated or certified by the product labeler.
What is the NDC Exclude Flag? This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions, or because the listing certification is expired, or because the listing data was inactivated by FDA, or because it was discontinued by the labeler. Possible values in this field are: "D", "E", "I", "N", "U".
